Hugh Kearney: Highlighting the Relevance of the Inflammasome in Multiple Sclerosis Pathophysiology
Hugh Kearney, Neurologist at Trinity College Dublin, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I am pleased to be involved in this new study from Eric Downer‘s lab in TCD – this new paper highlights the relevance of the inflammasome in the pathophysiology of MS.
NLRP3 has previously been highlighted to be of relevance to progression in MS and our study supports this.”
Title: Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple sclerosis
Authors: Almudena Otálora-Alcaraz, Melody Cui Sun, Nicole Hofman, Lisa Costelloe, Hugh Kearney, Jack A. Prenderville, Eric J. Downer
Read the Full Article on Multiple Sclerosis and Related Disorders.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?